Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
lundi, octobre 19
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Pyxis Oncology Inc
PYXS
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$1.76
0.08
4.76%
Dern. MÀJ: Oct 19, 4:36 PM
$1.78
0.10
5.95%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Privacy Manager
Pyxis Oncology Financials
Pyxis Oncology (PYXS) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Pyxis Oncology Q2 EPS $(0.40) Misses $(0.35) Estimate
Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.35) by 14.29 percent. This is a 33.33 percent decrease over losses of $(0.30) per share from
Benzinga Newsdesk
PRO
Pyxis Oncology Q1 EPS $(0.37), Inline
Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(0.37) per share which met the analyst consensus estimate. This is a 5.71 percent decrease over losses of $(0.35) per share from the same period last year.
Benzinga Newsdesk
PRO
Pyxis Oncology Q4 EPS $(0.29) Beats $(0.33) Estimate, Sales $11.038M
Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.33) by 12.65 percent. This is a 50.85 percent increase over losses of $(0.59) per share from
Benzinga Newsdesk
Nasdaq Gains Over 200 Points; US Inflation Slows To 2.7%
Avi Kapoor
PRO
Pyxis Oncology Q3 EPS $(0.35) Misses $(0.34) Estimate
Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.34) by 2.04 percent. This is unchanged from the same period last year.
Benzinga Newsdesk
PRO
Pyxis Oncology Q2 EPS $(0.30) Beats $(0.35) Estimate, Sales $2.82M
Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.35) by 14.77 percent. This is a 3.45 percent decrease over losses of $(0.29) per share from the
Benzinga Newsdesk
